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Objectives. This study compared the rates of coronary artery 
bypass graft surgery and 15-year survival for men and women 
after initial medical or surgical management. 
Background. There has been concern that women with coronary 
artery disease are managed differently than men and that men 
and women have a different prognosis. The Coronary Artery Sur- 
gery Study (CASS) registry is a large data base of well character- 
ized patients with long-term follow-up. 
Methods. Patients underwent cardiac catheterization at 1 of 15 
hospitals during 1974 to 1979. Bypass surgery rates were based on 
12,452 men and 2,366 women. Survival results were based on 6,018 
men and 1,095 women with operable coronary artery disease and 
initial medical management and 6,922 men and 1,291 women 
initially managed surgically. 
Results. At 15 years, bypass surgery rates were 75% for men and 
72% for women (p = 0.91). The rates remained similar after 
adjustment for clinical and angiographic variables. The 15-year 
survival rate was 50% for men and 49% for women with initial 
medical treatment (p = 0.53) and 52% for men and 48% for 
women (p = 0.004) with initial surgical treatment, a difference 
similar to that for operative mortality (men 2.5%, women 5.3%, 
p < 0.0001). Survival was improved by bypass surgery in most 
subgroups, with largest relative risks for high risk patients. 
Relative risks were similar for men and women. 
Conclusions. The rate of bypass surgery did not differ between 
men and women. There were few differences in the survival of men 
and women. In general, both men and women with initial surgical 
treatment survived longer, although benefits were clinically and 
statistically significant only in those at high risk. The benefit was 
similar in both men and women. 
(J Am Coll Cardiol 1995;25:1000-9) 
In January 1992, the National Heart, Lung, and Blood Institute 
convened an invitational conference entitled "Cardiovascular 
Health and Disease in Women" (1) to highlight new informa- 
tion derived from epidemiologic and clinical research. The 
conference r commended that information from existing clin- 
ical trials and registries be analyzed to compare the features of 
coronary heart disease in women and men with respect o 
baseline characteristics, clinical manifestations, responses to 
treatment and clinical outcomes (1). The present report pre- 
sents the 15-year survival for men and women in the Coronary 
Artery Surgery Study (CASS) registry who had either initial 
medical or surgical management. The purpose of this report 
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was to determine whether clinically comparable men and 
women are referred for bypass surgery at the same rate 
and whether they have similar survival with initial medical and 
surgical therapy. 
In recent years there has been increasing concern about 
the management of women with ischemic heart disease. 
Some investigators (2,3) have suggested that men and 
women have been managed ifferently when presenting with 
symptoms or signs of myocardial ischemia nd that women 
are less likely to have appropriate diagnostic evaluation and 
referral for coronary angiography. The appropriateness of 
referral for angiography cannot be addressed by CASS 
registry data because patients were entered into the registry 
after coronary arteriography. However, we were able to 
evaluate bypass surgery in patients who were evaluated for 
this procedure by angiography and to adjust the rates of 
surgical intervention i  men and women for both clinical 
and angiographic patient characteristics. Evaluation of re- 
ferral for bypass urgery and the subsequent 15-year survival 
period provides useful information with regard to physician 
management of men and women with established coronary 
artery disease between 1974 and 1979 and the resultant 
long-term outcome. 
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Methods  
Patients. The CASS trial was initiated in 1972 by the 
National Heart, Lung, and Blood Institute to compare coro- 
nary artery bypass graft surgery with conventional medical 
therapy for coronary artery disease. Complete details of the 
CASS design and protocol have been published elsewhere (4). 
The study was carried out at 15 participating medical centers in 
the United States and Canada and was designed as a random- 
ized trial within a larger egistry. For the registry, every patient 
who had coronary angiography for evaluation of suspected 
ischemic heart disease during the period of enrollment from 
1974 to 1979 was asked to participate. Patients were enrolled 
after giving informed consent. The 24,958 registry patients 
comprised 94% of the patients eligible to enter the CASS 
registry. Annual follow-up of the registry was solicited through 
November 1982, with follow-up obtained in 99% of patients. A
follow-up questionnaire was administered by mail between 
1988 and 1991, with response obtained in 94%. Vital status was 
determined through 1989 by the National Death Index for 
most of the remaining patients. 
There are 18,876 men and 6,082 women in the CASS 
registry population. Of these, 1250 men and 241 women were 
excluded from the present analysis because they had had 
previous cardiac surgery. In the remaining 23,467 patients, 
4,486 men and 3,401 women were excluded because they did 
not meet he definition of operable coronary artery disease. A 
patient was considered to have operable coronary disease if 
there was at least one major vessel with at least 50% stenosis 
and a distal vessel of normal size. In addition, there had to be 
at least 70% stenosis in a one of the coronary artery segments. 
Of the patients excluded for nonoperable coronary disease, 
2,121 men (11%) and 2,343 women (39%) had normal coro- 
nary arteries. Nineteen patients with operable coronary disease 
had zero-vessel disease by CASS definition and were grouped 
with patients with single-vessel disease for the present analysis. 
Statistical analysis. Rates of bypass urgery over time after 
angiography were estimated by Kaplan-Meier time-to-event 
analyses. Randomized patients were excluded from analyses of 
bypass urgery rates. Patients who died were censored at time 
of death. Comparison of rates between men and women was 
adjusted for differences between these two populations with 
regard to distribution of number of vessels diseased and 
Canadian Cardiovascular Society classification by using a 
stratified log-rank test. The comparison was adjusted for othcr 
covariates by using the Cox regression model for surviwd 
analysis, including terms for interaction with gender. 
Survival rates for men and women were estimated to 15 
years and compared by the log-rank statistic and Cox regres- 
sion analysis. Survival experience to 8 years for medically and 
surgically treated patients was also compared by the log-rank 
statistic and Cox regression analysis. Beyond 8 years, survival 
experience for medically and surgically treated patients was 
compared by the difference in truncated mean survival esti- 
mates (5,6). Mean survival truncated at 14 years was chosen as 
the longest period over which mean survival could reliably be 
estimated for all subgroups of interest. This measure of 
survival is equal to the area under the survival curve truncated 
at 14 years. Mean survival was used because the survival curves 
for medically and surgically treated patients began to come 
together after 8 years, and proportional hazards could not be 
assumed. 
Patients were considered to be medically treated if they did 
not have bypass urgery within the time period at each center 
during which 95% of the operations in the first year occurred; 
other patients were considered to be surgically treated. Sur- 
vival for surgical patients was dated from the time of operation. 
Survival for medical patients was dated from the average time 
to operation at each center, which excluded 200 men and 54 
women without bypass surgery because they died before the 
average time to operation. This method eliminates the bias 
that occurs when all the early deaths are included in the 
medical group. 
Covariates included in the Cox analyses were gender, age, 
current smoker, former smoker, diabetes, hypertension, pe- 
ripheral artery disease, angina, unstable angina, Canadian 
Cardiovascular Society angina class, number of major coronary 
arteries diseased (one to three), inferior myocardial jeopardy, 
anterior myocardial jeopardy, percent left main coronary ar- 
tery stenosis, previous myocardial infarction, congestive heart 
failure score and left ventricular score. First, a model was built 
that included gender and all covariates, with backward elimi- 
nation of the covariates until only the covariates with p < 0.001 
remained. Interactions of gender with each of the covariates 
left in the model were then added to the model, and backward 
elimination of the interactions was done until only interac- 
tion terms with p < 0.001 remained. The p value for gender 
reported in each analysis is the value when only covariates with 
p < 0.001 were in the model. These covariates are listed for 
each analysis. 
Resu l ts  
Patient characteristics. Characteristics of the 12,940 men 
and 2,386 women who had operable coronary disease and were 
included in the medical-surgical comparisons are presented in
Table 1. For the whole group the average age was 57 years for 
women and 54 for men (p < 0.0001). Women were more likely 
to have diabetes; men were more likely to be former smokers. 
Women had significantly more class III and IV angina and 
angina unrelated to exertion. Men had more three-vessel 
disease than women. The prevalence of left main coronary 
artery disease was similar. Table 2 shows the distribution of the 
severity of angina as related to number of diseased vessels. 
Given the same number of diseased coronary arteries, women 
had more class Ill to IV angina and angina unrelated to 
exertion (Fig. 1). 
Paradoxically, women more often had a history of conges- 
tive heart failure, whereas men more often had a history of 
myocardial infarction and worse left ventricular scores. 
Rates of coronary bypass surgery. There were 12,452 non- 
randomized men and 2,366 nonrandomized women who had 
1002 DAVIS ET AL. JACC Vol. 25, No. 5 
CASS MEN AND WOMEN WITH CAD April 1995:1000-9 
Table 1. Baseline Characteristics 
Initial Medical Therapy* Initial Surgical Therapy* 
Men Women Men Women 
(n = 6,018) (n = 1,095) (n = 6,922) (n = 1,291) 
Mean (_+SD) age (yr) 52.9 _+ 9.0 55.7 + 9.4 54,6 + 8.5 57.5 _+ 8.7 
CCS class 
No angina 26% 17% 8% 5% 
I 7% 3% 4% 3% 
II 31% 23% 22% 15% 
Ill 22% 33% 38% 38% 
IV 7% 13% 21% 31% 
Angina unrelated to exertion 7% 11% 8% 9% 
Unstable angina 20% 32% 41% 52% 
Congestive heart failure 12% 21% 9% 14% 
Hypertension 32% 49% 33% 50% 
Diabetes 11% 18% 11% 16% 
Peripheral arterial disease 10% 14% 10% 14% 
Smoker 
Current 35% 36% 30% 35% 
Former 49% 31% 52% 32% 
Never 16% 33% 19% 33% 
Previous MI 65% 55% 56% 48% 
Extent of disease 
0-1 vessel 36% 49% 16% 24% 
2 vessels 33% 29% 31% 34% 
3 vessels 31% 22% 53% 43% 
LMCA disease 4% 4% 14% 12% 
Mean (=SD) left ventricular score 9.2 _+ 4.3 8.4 _+ 4.2 8.3 -+ 3.7 7.6 _+ 3.5 
*p < 0.0001 for all differences between men and women within treatment groups, except p = NS for left main 
coronary artery (LMCA) disease. CCS = Canadian Cardiovascular Society; LV = left ventricular; MI = myocardial infarction. 
operable disease. The rates of men and women undergoing 
coronary artery bypass urgery were similar (Fig. 2). One year 
after angiography, the rate was 57% for men and 58% for 
women. By 15 years, the bypass urgery rate was 75% for men 
and 72% for women (p = 0.91). 
When patients were stratified by number of diseased 
coronary arteries, it appeared that more women than men 
had bypass surgery at 1 year: 38% of women versus 36% of 
men with one-vessel disease (p = 0.21); 62% of women 
versus 56% of men with two-vessel disease (p = 0.0003); and 
74% of women versus 70% of men with three-vessel disease 
(p = 0.0006). When adjusted by stratification for the 
different distribution of number of diseased vessels in the 
male and female populations, the bypass surgery rates over 
15 years were significantly higher for women (p -- 0.0004). 
In contrast, when patients were stratified by angina class, it 
Table 2. Angina Classification According to Extent of Coronary Artery Disease in Men and Women* 
Angina Unrelated Total No. 
No Angina CCS Class 1-II CCS Class Ill-IV to Exertion of Pts 
1-vessel disease 
Men 709 (22) 1,129 (35) 1,138 (35) 294 (9) 3,270 
Women 140 (17) 213 (25) 405 (48) 88 (10) 846 
2-vessel disease 
Men 732 (18) 1.358 (33) 1.739 (42) 320 (8) 4,149 
Women 62 (8) 150 (20) 462 (62) 73 (10) 747 
3-vessel disease 
Men 652 (12) 1,558 (28) 2,964 (54) 345 (6) 5,519 
Women 51 (6) 144 (18) 527 (67) 70 (9) 792 
Total 
Men 2,093 (16) 4,045 (31) 5,841 (45) 959 (7) 12,938 
Women 253 (11) 507 (21) 1,394 (58) 231 (10) 2,385 
*Two men and one woman with incomplete data were excluded. Data presented are number (%) of patients (Pts). 
CCS = Canadian Cardiovascular Society. 
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Figure 1. Percent of men and women with single-, double- and 
triple-vessel coronary artery disease and Canadian Cardiovascular 
Society class III or IV angina or angina unrelated to exertion. 
appeared that relatively more men had bypass surgery (p < 
0.0001). 
When both number of diseased vessels and angina class 
were considered, there was no difference in the rates of bypass 
surgery for men and women (p = 0.35 by the stratified log-rank 
test). These covariates, along with age, current smoking, 
peripheral arterial disease, unstable angina, percent left main 
coronary artery stenosis, inferior myocardial jeopardy, anterior 
myocardial jeopardy and left ventricular score, were used in a 
Cox regression model with gender. The results of this analysis 
indicate that gender was not significantly related to selection of 
patients for bypass urgery (p = 0.11). 
Survival with initial medical management. There were 
6,018 men and 1,095 women with operable disease who did not 
have early coronary artery bypass urgery. The survival rate at 
15 years was 50% for men and 49% for women (p = 0.53) (Fig. 
3). During this period, 24% of these women and 28% of these 
men had bypass urgery. 
The 15-year survival rate was similar for men and women 
within categories of angina: 54% in women and 50% in men 
without angina (p = 0.12); 58% in men and 57% in women 
with class I or II angina (p = 0.67); and 42% in both men and 
women with class III or IV angina or angina unrelated to 
exertion. 
Survival was not significantly different (p > 0.11) between 
men and women with one- and two-vessel disease. However, 
the 15-year survival rate for men with three-vessel disease was 
much higher than that for women (34% versus 19%, respec- 
tively, (p < 0.0001). 
In patients with a normal or minimally abnormal left 
ventricular score <10, the 15-year survival rate was 64% for 
men and 59% for women (p = 0.07). For those with a left 
ventricular score ->10, the 15-year survival rate was 30% in 
men and 27% in women (p = 0.16). There was a marked 
interaction between left ventricular score and presence of 
three-vessel disease (Fig. 4). For patients with three-vessel 
disease and a left ventricular score <10, the 15-year survival 
rate was 52% for men and 28% for women (p < 0.0001). For 
those with three-vessel disease and a left ventricular score -> 10, 
the 15-year survival rate was poor for both men and women 
(18% vs. 12%, respectively, p = 0.03). 
To determine the effect of gender on predicting survival 
with initial medical therapy, the patient's gender was entered 
into a Cox regression model along with age, current smoking, 
diabetes, hypertension, congestive heart failure score, previous 
myocardial infarction, left ventricular score, percent left main 
coronary artery stenosis and number of vessels diseased. When 
this was done, gender was not a significant predictor of survival 
(0.94 relative risk for women, p = 0.29). When interactions 
were added, there was a significant negative interaction of 
gender with left ventricular score (higher risk in men than 
women with severe left ventricular dysfunction, p < 0.001) if 
the interaction of gender with number of diseased vessels 
(higher risk in women than men with three-vessel disease, p = 
0.01) was also in the model. 
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Figure 3. Percent survival of men and women 
with initial medical management. 
Survival with initial surgical management. There were 
6,922 men and 1,291 women with operable disease who had 
early coronary artery bypass urgery. Operative mortality rate 
was 2.5% in men and 5.3% in women (p < 0.0001). Survival 
rate at 15 years was 52% in men and 48% in women (p = 
0.004), a difference similar to the initial difference in operative 
mortality rates (Fig. 5). 
Differences in long-term survival were minor for men and 
women within categories of preoperative angina. At 15 years 
the survival rate was 52% in men and 53% in women without 
preoperative angina (p = 0.49) and 60% in both men and 
women with class I or II angina before bypass surgery. In 
patients with class III or IV angina or angina unrelated to 
exertion, the 15-year survival rate was 47% in men and 43% in 
women (p = 0.03). 
The primary differences in 15-year survival between men 
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Figure 4. Percent survival of men and women with 
three-vessel disease and a left ventricular score <10 
(lop) or -> 10 (bottom) who underwent initial medical 
management. 
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Figure 5. Percent survival of men and 
women with initial surgical management. 
Operative mortality was 2.5% in men and 
5.3% in women. 
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and women occurred in patients with more severe coronary 
artery disease. For one-vessel disease, the 15-year survival rate 
was 66% in men and 69% in women (p = 0.89), and the 
operative mortality rate was 1.1% in men and 3.3% in women 
(p = 0.006). For two-vessel disease, the 15 year survival rate 
was 56% in men and 51% in women (p = 0.04), and the 
operative mortality rate was 1.9% in men and 5.1% in women 
(p = 0.0001). For three-vessel disease, the 15-year survival rate 
was 45% in men and 32% in women (p < 0.0001), and the 
operative mortality rate was 3.2% in men and 6.7% in women 
(p < 0.0001). This difference in 15-year survival for patients 
with three-vessel disease was significant (p = 0.00l) even when 
operative mortality was excluded. 
For patients with a left ventricular score <10, the 15-year 
survival rate was 60% in men and 52% in women (p = 0.0009), 
and the operative mortality rate was 1.6% in men and 4.7% in 
women (p < 0.0001). The survival rate at 15 years for patients 
with a left ventricular score ->10 was 36% in men and 32% in 
women (p = 0.002), and the operative mortality rate was 4.2% 
in men and 7.8% in women (p = 0.005). The difference was 
greatest for patients with three-vessel disease and a left 
ventricular score ->10. At 15 years, the survival rate was 32% 
for men and 21% for women (p < 0.0001), and the operative 
mortality rate was 4.7% for men and 8.4% for women (p = 
0.03). For patients with three-vessel disease and a left ventric- 
ular score <10, the operative mortality rate was 2.3% for men 
and 6.4% for women (p < 0.0001), and the 15-year survival 
rate was 54% for men and 37% for women (p = 0.0004). 
The differences in survival between men and women that 
were observed in some subcategories were a result of many 
factors that influence risk. Gender did not add significant 
predictive information (0.96 relative risk for women, p = 0.43) 
when it was included in a Cox regression model with age, 
current smoking, diabetes, hypertension, peripheral arterial 
disease, congestive heart failure score, left ventricular score 
and number of vessels diseased. There were no significant (p < 
0.001) interactions with gender. 
Comparison of survival with initial medical or surgical 
therapy. The 8-year survival data for categories of left ventric- 
ular score, age and number of vessels diseased are shown in 
Table 3 for men and women who had initial medical or surgical 
therapy. In almost every category the proportion surviving at 8 
years is larger for patients with initial surgical management. In 
only three of these categories was initial medical therapy 
superior to initial surgical therapy (relative risks <1, and none 
of these is statistically significant). The relative risks are 
greatest for those patients at highest risk, including those with 
three-vessel disease or a left ventricular score >9 and those 
>64 years old. The difference in relative risks for men and 
women was tested by using gender, therapy, age, left ventric- 
ular score and number of vessels diseased in a Cox model of 
8-year survival with an interaction term for each covariate with 
therapy. The individual terms and the terms for interaction 
with therapy were each significant (p < 0.0001) for the other 
covariates, but the interaction term for gender and therapy was 
not significant (p = 0.57). Thus, the benefit of bypass urgery 
is similar for men and women, as indicated in Table 3 by the 
similarity of the relative risks for men and women within each 
subcategory of the other covariates. 
Overall survival to 15 years is shown for medically and 
surgically managed men and women in Figure 6. The mortality 
rate of patients managed with initial bypass urgery increased 
after 8 years, probably as a result of closure of the saphenous 
vein grafts, so that at 15 years the survival rates were similar for 
surgically and medically managed patients. Even though the 
survival rates at 15 years were similar, mean survival time was 
greater for patients initially treated with bypass urgery. Mean 
survival time, truncated at 14 years for several subgroups, is 
shown in Table 4. As was the case with 8-year survival rates, the 
benefit of initial bypass surgery in terms of extended years of 
life over 14 years of follow-up is greatest in those patients at 
highest risk. For patients <65 years old, with a left ventricular 
score <10 and one-vessel disease, the added years of life were 
only 0.1 year for men and women. For patients >64 years old 
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Table 3. Eight-Year Percent Survival and Relative Risk for Men and Women With Initial Medical or Surgical Management 
Single-Vessel CAD Double-Vessel CAD Triple-Vessel CAD 
Medical Surgical Rel Risk Medical Surgical Rel Risk Medical Surgical Rel Risk 
LV score <10 
Age <65 yr 
Men 1,436 (89) 854 (92) 1.04' 1,063 (84) 1,367 (89) 1.1)6' 732 (75) 1,836 (83) 1.11' 
Women 348 (89) 242 (92) 1.03 169 (80) 259 (82) 1.03 74 (62) 259 (77) 1.26" 
Age ->65 yr 
Men 91 (70) 54 (76) 1.08 84 (68) 141 (82) 1.20' 116 (53) 315 (72) 1.36' 
Women 52 (87) 30 (80) 0.92 34 (65) 60 (73) 1.12 32 (56) 99 (73) 1.30 
LV score >10 
Age <65 yr 
Men 553 (75) 149 (82) 1.09 726 (60) 527 (76) 1.27" 840 (41) 1,160 (69) 1.70" 
Women 107 (70) 25 (67) 0.96 77 (54) 76 (72) 1.33" 88 (36) 112 (58) 1.62' 
Age >65 yr 
Men 29 (48) 26 (69) 1.43 70 (36) 63 (59) 1.64' 160 (22) 193 (53) 2.47* 
Women 20 (64) 4 (50) 0.79 21 (43) 24 (66) 1.54 38 (22) 54 (54) 2.42* 
Total 
Men 2,162 (84) 1,109 (89) 1.07' 1,980 (72) 2,169 (84) 1.17' 1,876 (53) 3,644 (76) 1.41 *
Women 541 (84) 305 (88) 1.05 312 (69) 435 (78) 1.13' 242 (44) 551 (70) 1.56' 
*p < 0.05, different from 1.00. Data presented are number of patients (8-year percent survival). CAD = coronary artery disea~; LV = left ventricular; Rel = relative. 
with a left ventricular score >9 and three-vessel disease, initial 
surgical management added 3.6 years of life for men and 3.7 
years for women. 
In general, mean survival within categories of risk was 
similar for men and women. Significant differences between 
men and women were observed in only four subgroups. These 
include patients <65 years old with two-vessel disease, a left 
ventricular score <10 and bypass surgery; patients <65 years 
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Figure 6. Percent survival of men (top) and women 
(bottom) treated with initial medical and surgical 
management. 
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Table 4. Mean Years of Survival Truncated at 14 Years and Differences for Men and Women With Initial Medical or Surgical Management 
Single-Vessel CAD Double-Vessel CAD Triple-Vessel CAD 
Medical Surgical Diff Medical Surgical Diff Medical Surgical Diff 
LV score <10 
Age <65 yr 
Men 12.6 
Women 12.6 
Diff 0.0 
Age >65 yr 
Men 10.3 
Women 11.7 
Diff 1.3 
LV score >-10 
Age <65 yr 
Men 1(/.9 
Women 10.6 
Diff 0.3 
Age ->65 yr 
Men 7.9 
Women 8.8 
Diff -0.9 
12.7 0.1 
12.7 0.1 
0.1 
I 1.0 0.7 
10.9 0.8 
0.1 
11.5 0.6 
9.7 -0.9 
1.8 
m E 
m 
12.1) 12.3 0.3 * 11.11 11.8 0.9* 
11.5 11.6 0.1 9.3 11t.9 1.6" 
0.5 0.7t 1.6t 0.9? 
10.2 11.3 1.0 8.2 10.1 1.8' 
10.0 10.4 0.5 8.6 10.5 1.9" 
0.3 I).8 -0.4 -0.4 
9.2 10.7 1.6" 6.9 10.l 3.1' 
8.3 111.6 2.3* 6.4 8.5 2.1" 
0.9 0.1 0.5 1.5t 
5.8 8.6 2.8* 4.6 8.2 3.6* 
7.2 9.4 2.2 4.0 7.8 3.7* 
1.4 -0.9 0.6 0.5 
*p < 0.05, difference (Diff) between su~'ival with initial medical and initial surgical management, tp < 0.05, difference between men and women. Abbreviations 
as in Table 3. 
old with three-vessel disease, a left ventricular score <10 and 
either initial medical or surgical management; and patients 
<65 years old with three-vessel disease, a left ventricular score 
>-10 and surgical management. These differences are not 
significant after correction for multiple comparisons by the 
Bonferroni method and should be interpreted cautiously be- 
cause of the large number of statistical test results reported for 
these many subsets of patients. 
Discuss ion  
Rates of bypass surgery. A recent study (2) compared 
nearly 50,000 men and women who were hospitalized in 
Massachusetts and Maryland for acute myocardial infarction, 
unstable angina, angina pectoris, chronic ischemic heart dis- 
ease or nonrespiratory chest pain in 1987. The investigators 
found that men had coronary bypass surgery at much higher 
rates than women. This difference persisted espite adjustment 
for a number of clinical characteristics, including age, conges- 
tive heart failure, diabetes and race. Unfortunately, because 
the investigators did not have information about coronary 
anatomy or status of left ventricular function, they would not 
have been able to come to any meaningful conclusion about 
the appropriate use of revascularization procedures in either 
the men or the women in their study population. 
In the CASS registry, 39% of women and 11% of men had 
normal coronary arteries. If these patients, who had coronary 
arteriography for suspected ischemic coronary disease, had 
been included in our analysis of bypass urgery rates, it would 
have appeared that women were less often referred for surgical 
treatment. Even in our study population, which was restricted 
to those CASS patients appropriate for bypass urgery, if the 
adjustment used only clinical characteristics, the men appeared 
to have a higher ate of surgical intervention. With restriction 
to a population appropriate for bypass urgery and adjustment 
for both clinical and angiographic characteristics, the rates for 
men and women were not different. Thus, it is critically 
important for studies that compare rates of procedural utiliza- 
tion in men and women to adjust for both symptoms and 
severity of coronary artery disease and left ventricular dysfunc- 
tion. Without simultaneous adjustment, rate estimates may be 
seriously biased. 
Although we cannot judge the appropriateness of the use of 
coronary angiography in our study because this procedure was 
the starting point for enrollment in the CASS registry, there is 
no evidence that angiography was underutilized in women in 
the CASS registry because women were found to have signif- 
icantly less coronary artery disease than men in the registry. 
A study (7) of 4,707 men and 1,088 women with coronary 
artery disease who were enrolled in the Duke data registry 
showed referral rates to bypass surgery that were similar to 
ours. In the period 1969 to 1979, men and women who 
appeared to be equally likely to benefit from bypass surgery 
were referred in equal proportions. In the period 1980 to 1984, 
women with advanced coronary disease continued to be re- 
ferred for coronary bypass surgery at the same rate as men. 
However, during the same period, women were less likely to be 
referred for bypass surgery than men if the procedure was 
expected to control symptoms but not improve survival. The 
reluctance to refer low risk women to bypass surgery in this 
period may have resulted from reports during this time of 
higher operative mortality for women (8-12). 
Survival rates. Overall, the 15-year survival rates for men 
and women with initial medical management were similar. The 
1008 DAVIS ET AL. JACC Vol. 25, No. 5 
CASS MEN AND WOMEN WITH CAD April 1995:1000-9 
overall difference in 15-year survival rates for men and women 
with surgical management was approximately equal to the 
initial difference in operative mortality. When the Cox model 
was used to adjust for all covariates simultaneously, no signif- 
icant differences in 15-year survival related to gender were 
found. This result agrees with previous studies of 5- and 
10-year survival after bypass urgery that found no differences 
between men and women (9,12-16). In CASS as well as in 
other studies, the observed ifferences in operative mortality 
between men and women were in part due to the size of the 
patients and their coronary arteries rather than gender 
(12,17,18). The many improvements in anesthesia and surgical 
management that have occurred over the past 15 years have 
tended to decrease the differences in operative mortality 
between men and women (19). Thus, the estimates of early and 
long-term outcome for men and women described here need to 
be adjusted for the low surgical mortality currently experienced 
by both men and women. 
The long-term outcome of these patients has also been 
influenced by improvements in medical management during 
the past 15 years (e.g., use of calcium channel blocking agents 
for the management of myocardial ischemia, improved man- 
agement of unstable ischemic syndromes and marked advances 
in management of congestive heart failure). In addition, 
patients have benefited from the use of aspirin in recent years 
and the widespread use of effective lipid-lowering programs. 
The introduction of coronary artery balloon angioplasty in 
the late 1970s and its wide application just a few years later 
have undoubtedly influenced the outcome of many patients 
similar to those in the present CASS registry analysis. It is 
possible that the use of angioplasty has bad a greater influence 
in patients with initial medical versus initial surgical manage- 
ment. From the available CASS follow-up data, it was not 
possible to determine the relative role of angioplasty and 
bypass urgery in the outcome of patients in the present study. 
Truncated mean survival. Between 8 and 10 years after 
bypass urgery, the slope of the surgical survival curve becomes 
steeper as a result of an increase in mortality during this 
period. This is consistent with previously published data 
(20,21) that showed this to be a period of increasing likelihood 
of closure of saphenous vein grafts. The difference in percent 
survival between the medical and surgical groups diminishes 
over time, so that at 14 to 15 years the survival rate is similar. 
To emphasize that an important difference in the shape of the 
survival curves exists even though survival rates at 14 years are 
similar, we compared the 14-year survival experiences by 
comparing the areas under the survival curves. This area 
represents he mean survival time truncated at 14 years, and 
the difference in mean survival times is an estimate of the 
number of years of life added by initial surgical treatment. 
When mean survival time truncated at 14 years was com- 
pared for patients who were initially managed surgically or 
medically, the greatest benefit was seen in surgically managed 
patients with extensive coronary artery disease and decreased 
left ventricular function. For patients ->65 years old with a left 
ventricular score ->10 and three-vessel disease, the difference 
in mean survival time between initial surgical and medical 
management was 3.6 years for men and 3.7 years for women. 
For patients with single-vessel disease, the difference in mean 
survival time was only 0.1 to 0.7 years for men and 0.1 to 0.9 
years for women. As was true in the comparison of 8-year 
survival times, there was little difference in benefit between 
men and women within most subgroups. 
Conclusions. In a large population from the CASS reg- 
istry, we compared the use of bypass surgery and survival 
over 15 years for men and women who were initially treated 
with and without bypass urgery. The rate of bypass utiliza- 
tion did not differ significantly between men and women, 
and there were few differences in their long-term survival. 
On average, survival of men and women treated with 
medical therapy was similar, and survival after 15 years for 
men and women with initial bypass urgery differed only by 
their difference in operative mortality. Overall, patients 
treated initially with bypass surgery survived longer, al- 
though the benefits were significant only in those patients 
who were at highest risk. The survival benefit of bypass 
surgery was similar for both men and women. 
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